Novorapid vs. Actrapid: Key Differences for Diabetes Management
Both Novorapid (insulin aspart) and Actrapid (human insulin) are short-acting insulins for mealtime blood sugar control, but differ in pharmacokinetics:
1. Speed of Action
- Novorapid: Onset ~10–20 minutes; peaks quickly—ideal for mimicking natural post-meal insulin release.
- Actrapid: Onset ~30–60 minutes; slightly slower peak.
2. Duration of Action
- Novorapid: 3–5 hours—shorter coverage, allows frequent dose adjustments.
- Actrapid: 6–8 hours—longer coverage, suited for less frequent dosing or stable patterns.
3. Side Effect Profile
- Novorapid: Slightly higher hypoglycemia risk due to rapid onset/short duration.
- Actrapid: Rare allergic reactions (rash, itching) reported more often.
Choice depends on individual glucose patterns, meal routines, lifestyle, and physician assessment. Always consult your healthcare provider.
Diabetes - Related Articles
- Prediabetes: Understanding, Management & Reversal Strategies
- Humalog vs. Novolog: A Comprehensive Comparison for Diabetes Management
- Understanding Untreated Diabetes: Symptoms & Types
- Arteries Most Affected by Diabetic Vascular Disease
- Diabetes Treatment & Management: Preventing Complications & Improving Life Expectancy
- High-Protein Diets for Diabetes: Benefits & Risks
- GlucoWatch: A Comprehensive Guide to Purchase and Usage
